MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Parkinson's Disease
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Bay City Capital
Finance & Acquisition: Bay City
*Portfolio Companies: Bay City
Poniard Pharmaceuticals (NASDAQ: PARD)
Parents
*Portfolio Companies: Bay City
Architects: Cancer & Oncology Companies
Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
Children
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ (2011)
Designed to overcome platinum-based chemoresistance
Develops and commercializes oncology products.
Founded 1984
Its current focus is Picoplatin, a next-generation platinum therapy with improved safety features
Poniard Pharmaceuticals Inc and Allozyne Inc Terminate Planned Merger (2011)